Repligen | Marktkapitalisierung



Market Capitalization Veränderung Datum
Align Technology USD 15.57B 3.43B 2024-12
Bio Techne USD 11.44B 1.24B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Bruker USD 8.89B 1.57B 2024-12
Charles River Laboratories USD 9.44B 730M 2024-12
Danaher USD 165.8B 34.99B 2024-12
Dentsply International USD 3.77B 1.71B 2024-12
Exact Sciences USD 10.4B 2.19B 2024-12
General Electric USD 180.52B 23.96B 2024-12
Henry Schein USD 8.63B 609M 2024-12
Illumina USD 21.19B 420M 2024-12
IQVIA Holdings USD 35.67B 7.53B 2024-12
Mettler Toledo International USD 25.82B 6B 2024-12
Myriad Genetics USD 1.25B 1.24B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Repligen USD 8.07B 270M 2024-12
Revvity USD 13.58B 2.17B 2024-12
Standard Biotools USD 716M 61M 2024-09
Thermo Fisher Scientific USD 198.99B 37.61B 2024-12
Waters USD 22.03B 657M 2024-12
West Pharmaceutical Services USD 23.72B 1.95B 2024-12



Repligen Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.